side effects of tirzepatide vs semaglutide Comparative safety and and tirzepatide: Implications for clinical decision-making in obesity management Weighing up the Risks: GI

But lithium probably does not cause much weight gain, something that we can reassure our patients about, that if it does, it's not statistically detectable

The microdosing phase ends when you reach 2.5 mg weekly (the standard starting dose)

Patients should be honest about their medical history and any other medications they take

This response can lead to inflammation and rash

In August 2023, the first lawsuits were filed against Novo Nordisk, the manufacturer of Ozempic and Wegovy, as well as Eli Lilly, the manufacturer of similar GLP-1 agonist drugs

An every other week schedule helps patients shift from dependent to a supportive tool mindset